These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 12387034

  • 21. Characteristics of type 2 diabetic patients responding to voglibose administration as an adjunct to sulfonylurea.
    Hirose T, Miyashita Y, Takagi M, Sumitani S, Kouhara H, Kasayama S.
    Diabetes Res Clin Pract; 2001 Oct; 54(1):9-15. PubMed ID: 11532325
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Effects of alpha-glucosidase inhibitor (acarbose) combined with sulfonylurea or sulfonylurea and metformin in treatment of non-insulin-dependent diabetes mellitus.
    Vannasaeng S, Ploybutr S, Nitiyanant W, Peerapatdit T, Vichayanrat A.
    J Med Assoc Thai; 1995 Nov; 78(11):578-85. PubMed ID: 8576667
    [Abstract] [Full Text] [Related]

  • 24. Effect of an alpha-glucosidase inhibitor combined with sulphonylurea treatment on glucose metabolism in patients with non-insulin-dependent diabetes mellitus.
    Okada S, Ishii K, Tanokuchi S, Hamada H, Ichiki K, Ota Z.
    J Int Med Res; 1995 Nov; 23(4):279-83. PubMed ID: 7589771
    [Abstract] [Full Text] [Related]

  • 25. [Oral hypoglycemic agents--overview].
    Sakamoto N, Uno T.
    Nihon Rinsho; 1997 Nov; 55 Suppl():94-8. PubMed ID: 9434450
    [No Abstract] [Full Text] [Related]

  • 26. [Glimepiride].
    Nakamura N.
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():351-6. PubMed ID: 12387017
    [No Abstract] [Full Text] [Related]

  • 27. The efficacy of voglibose on glycemic excursions in non-insulin-treated NIDDM patients.
    Yoshioka K, Yokoo S, Yoshida T.
    Diabetes Care; 1998 Jul; 21(7):1206-7. PubMed ID: 9653625
    [No Abstract] [Full Text] [Related]

  • 28. [Adverse effects of oral hypoglycemic agents].
    Mori Y, Sekihara H.
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():325-31. PubMed ID: 12387013
    [No Abstract] [Full Text] [Related]

  • 29. [Proper selection and practical administration of sulphonylurea agents to diabetics].
    Kurahachi H.
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():346-50. PubMed ID: 12387016
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Effects of voglibose on glycemic excursions, insulin secretion, and insulin sensitivity in non-insulin-treated NIDDM patients.
    Matsumoto K, Yano M, Miyake S, Ueki Y, Yamaguchi Y, Akazawa S, Tominaga Y.
    Diabetes Care; 1998 Feb; 21(2):256-60. PubMed ID: 9539992
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Oral antihyperglycemic therapy for type 2 diabetes mellitus.
    Cheng AY, Fantus IG.
    CMAJ; 2005 Jan 18; 172(2):213-26. PubMed ID: 15655244
    [Abstract] [Full Text] [Related]

  • 35. [Combination therapy with insulin and sulfonylurea].
    Takamatsu J.
    Nihon Rinsho; 1997 Nov 18; 55 Suppl():255-60. PubMed ID: 9434477
    [No Abstract] [Full Text] [Related]

  • 36. [Current and future aspects of oral antidiabetic agents in type 2 diabetes].
    Rybka J.
    Vnitr Lek; 2001 May 18; 47(5):285-90. PubMed ID: 11395869
    [Abstract] [Full Text] [Related]

  • 37. Initiating oral anti diabetic drug: alternatives to metformin.
    Kalra S, Gupta Y.
    J Pak Med Assoc; 2015 Apr 18; 65(4):440-1. PubMed ID: 25976586
    [Abstract] [Full Text] [Related]

  • 38. Beneficial effect of long-term combined treatment with voglibose and pioglitazone on pancreatic islet function of genetically diabetic GK rats.
    Ishida H, Kato S, Nishimura M, Mizuno N, Fujimoto S, Mukai E, Kajikawa M, Yamada Y, Odaka H, Ikeda H, Seino Y.
    Horm Metab Res; 1998 Nov 18; 30(11):673-8. PubMed ID: 9918384
    [Abstract] [Full Text] [Related]

  • 39. [Combined insulin-sulfonylurea in type II diabetes mellitus--an update].
    Ravina A, Minuchin O.
    Harefuah; 1987 Nov 15; 113(10):285-7. PubMed ID: 3326798
    [No Abstract] [Full Text] [Related]

  • 40. Potential pharmacokinetics interference between alpha-glucosidase inhibitors and other oral antidiabetic agents.
    Scheen AJ, Lefèbvre PJ.
    Diabetes Care; 2002 Jan 15; 25(1):247-8. PubMed ID: 11772929
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.